{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:18:49Z","timestamp":1791875929953,"version":"4.3.4"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019042","name":"Jiangsu Ocean University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304275"],"award-info":[{"award-number":["82304275"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81703493"],"award-info":[{"award-number":["81703493"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003564"],"award-info":[{"award-number":["82003564"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22207094"],"award-info":[{"award-number":["22207094"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bioorg.2026.109785","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T15:52:07Z","timestamp":1774108327000},"page":"109785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Discovery of novel HDAC6 inhibitors based on the diphenyl-1,2,4-oxadiazole scaffold with potential efficacy in alleviating inflammation- and chemotherapy- associated mechanical hypersensitivity"],"prefix":"10.1016","volume":"175","author":[{"given":"Long","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiapei","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leikai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianya","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.109785_bb0005","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1021\/acs.jmedchem.1c00028","article-title":"Novel approaches, drug candidates, and targets in pain drug discovery","volume":"64","author":"Obeng","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109785_bb0010","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.tips.2019.04.003","article-title":"Novel approaches to persistent pain therapy","volume":"40","author":"Sisignano","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2026.109785_bb0015","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(21)01194-6","article-title":"Rethinking chronic pain","volume":"397","author":"The","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2026.109785_bb0020","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-pharmtox-010818-021524","article-title":"Neuropathic pain: mechanism-based therapeutics","volume":"60","author":"Bannister","year":"2020","journal-title":"Annu. Rev. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109785_bb0025","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/S0140-6736(21)00393-7","article-title":"Chronic pain: an update on burden, best practices, and new advances","volume":"397","author":"Cohen","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2026.109785_bb0030","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bioorg.2026.109785_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2058738419838383","article-title":"The neuropathic pain: an overview of the current treatment and future therapeutic approaches","volume":"33","author":"Cavalli","year":"2019","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109785_bb0040","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1152\/physrev.00045.2019","article-title":"Neuropathic pain: from mechanisms to treatment","volume":"101","author":"Finnerup","year":"2021","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bioorg.2026.109785_bb0045","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.tins.2015.02.001","article-title":"Epigenetic mechanisms of chronic pain","volume":"38","author":"Descalzi","year":"2015","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bioorg.2026.109785_bb0050","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3389\/fncel.2018.00158","article-title":"Epigenetic modifications associated to neuroinflammation and neuropathic pain after neural trauma","volume":"12","author":"Penas","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bioorg.2026.109785_bb0055","article-title":"histone deacetylase as emerging pharmacological therapeutic target for neuropathic pain: from epigenetic to selective drugs","volume":"30","author":"Zhang","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.bioorg.2026.109785_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1515787","article-title":"Histone deacetylases: the critical enzymes for microglial activation involved in neuropathic pain","volume":"16","author":"Ding","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109785_bb0065","first-page":"CD003945","article-title":"Valproate preparations for agitation in dementia","volume":"10","author":"Baillon","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bioorg.2026.109785_bb0070","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pneurobio.2015.05.002","article-title":"The epigenetics of aging and neurodegeneration","volume":"131","author":"Lardenoije","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bioorg.2026.109785_bb0075","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/acn3.147","article-title":"The promise and perils of HDAC inhibitors in neurodegeneration","volume":"2","author":"Didonna","year":"2015","journal-title":"Ann Clin Transl Neur"},{"key":"10.1016\/j.bioorg.2026.109785_bb0080","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1007\/s10787-024-01488-x","article-title":"HDAC inhibitors as a potential therapy for chemotherapy-induced neuropathic pain","volume":"32","author":"Manengu","year":"2024","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.bioorg.2026.109785_bb0085","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/s41593-023-01350-3","article-title":"Oxycodone withdrawal induces HDAC1\/HDAC2-dependent transcriptional maladaptations in the reward pathway in a mouse model of peripheral nerve injury","volume":"26","author":"Pryce","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bioorg.2026.109785_bb0090","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s12974-021-02273-1","article-title":"Sodium phenylbutyrate inhibits Schwann cell inflammation via HDAC and NF\u03baB to promote axonal regeneration and remyelination","volume":"18","author":"Yadav","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bioorg.2026.109785_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107332","article-title":"Valproic acid mitigates spinal nerve ligation-induced neuropathic pain in rats by modulating microglial function and inhibiting neuroinflammatory response","volume":"92","author":"Guo","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bioorg.2026.109785_bb0100","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1648919","article-title":"Comparison of different histone deacetylase inhibitors in attenuating inflammatory pain in rats","author":"Mao","year":"2019","journal-title":"Pain Res. Manag."},{"key":"10.1016\/j.bioorg.2026.109785_bb0105","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.tips.2021.08.002","article-title":"Histone post-translational modifications as potential therapeutic targets for pain management","volume":"42","author":"Torres-Perez","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2026.109785_bb0110","first-page":"336","article-title":"Phase 2 trial of the histone deacetylase inhibitor romidepsin for the treatment of refractory multiple myeloma","volume":"117","author":"Niesvizky","year":"2011","journal-title":"Cancer-Am Cancer Soc"},{"key":"10.1016\/j.bioorg.2026.109785_bb0115","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2119\/molmed.2011.00030","article-title":"HDAC inhibition in rheumatoid arthritis and juvenile idiopathic arthritis","volume":"17","author":"Vojinovic","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.bioorg.2026.109785_bb0120","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12974-020-01740-5","article-title":"Suppression of histone deacetylases by SAHA relieves bone cancer pain in rats via inhibiting activation of glial cells in spinal dorsal horn and dorsal root ganglia","volume":"17","author":"He","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bioorg.2026.109785_bb0125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.nbd.2017.11.011","article-title":"Inhibition of histone deacetylase 6 (HDAC6) protects against vincristine-induced peripheral neuropathies and inhibits tumor growth","volume":"111","author":"Van Helleputte","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bioorg.2026.109785_bb0130","doi-asserted-by":"crossref","DOI":"10.1177\/17448069231218352","article-title":"Spinal HDAC6 mediates nociceptive behaviors induced by chronic constriction injury via neuronal activation and neuroinflammation","volume":"19","author":"Sun","year":"2023","journal-title":"Mol. Pain"},{"key":"10.1016\/j.bioorg.2026.109785_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.109803","article-title":"HDAC6 inhibitor ACY-1215 improves neuropathic pain and its comorbidities in rats of peripheral nerve injury by regulating neuroinflammation","volume":"353","author":"Chen","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bioorg.2026.109785_bb0140","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1097\/j.pain.0000000000000893","article-title":"HDAC6 inhibition effectively reverses chemotherapy-induced peripheral neuropathy","volume":"158","author":"Krukowski","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.bioorg.2026.109785_bb0145","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1007\/s00213-020-05525-9","article-title":"HDAC6-selective inhibitors decrease nerve-injury and inflammation-associated mechanical hypersensitivity in mice","volume":"237","author":"Sakloth","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bioorg.2026.109785_bb0150","doi-asserted-by":"crossref","first-page":"424","DOI":"10.7150\/ijms.30154","article-title":"Histone deacetylases (HDACs) guided novel therapies for T-cell lymphomas","volume":"16","author":"Zhang","year":"2019","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.bioorg.2026.109785_bb0155","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1021\/jm7011408","article-title":"Histone deacetylase inhibitors: from bench to clinic","volume":"51","author":"Paris","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109785_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114634","article-title":"Discovery of 2,5-diphenyl-1,3,4-thiadiazole derivatives as HDAC inhibitors with DNA binding affinity","volume":"241","author":"Chen","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109785_bb0165","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1021\/acs.jmedchem.1c01863","article-title":"Discovery of novel histone deacetylase 6 (HDAC6) inhibitors with enhanced antitumor immunity of anti-PD-L1 immunotherapy in melanoma","volume":"65","author":"Peng","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109785_bb0170","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1021\/acs.jmedchem.5b01493","article-title":"Synthesis and biological investigation of oxazole hydroxamates as highly selective histone deacetylase 6 (HDAC6) inhibitors","volume":"59","author":"Senger","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109785_bb0175","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1021\/acschemneuro.1c00841","article-title":"Epigenetic mechanisms of neural plasticity in chronic neuropathic pain","volume":"13","author":"Ghosh","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2026.109785_bb0180","doi-asserted-by":"crossref","DOI":"10.1177\/17448069211056767","article-title":"Epigenetic modifications in neuropathic pain","volume":"17","author":"Luo","year":"2021","journal-title":"Mol. Pain"},{"key":"10.1016\/j.bioorg.2026.109785_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.pscia.2025.100099","article-title":"Discovery of a long-acting nanocrystal formulation of INND-2201, a new co-drug of pregabalin and palmitoylethanolamide with synergistic analgesic effects","volume":"3","author":"Han","year":"2025","journal-title":"Pharm Sci Adv"},{"key":"10.1016\/j.bioorg.2026.109785_bb0190","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.7150\/thno.69424","article-title":"Platinum-based drugs for cancer therapy and anti-tumor strategies","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"issue":"24","key":"10.1016\/j.bioorg.2026.109785_bb0195","first-page":"S6","article-title":"T.N. Consortium, Chemotherapy-induced peripheral neurotoxicity: A multifaceted, still unsolved issue","author":"Cavaletti","year":"2019","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.bioorg.2026.109785_bb0200","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1080\/14728222.2024.2404571","article-title":"Therapeutic indications for HDAC6 inhibitors in the peripheral and central nervous disorders","volume":"28","author":"van Eyll","year":"2024","journal-title":"Expert Opin Ther Tar"},{"key":"10.1016\/j.bioorg.2026.109785_bb0205","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/WCO.0000000000000724","article-title":"Toxic neuropathies: chemotherapy induced peripheral neurotoxicity","volume":"32","author":"Alberti","year":"2019","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.bioorg.2026.109785_bb0210","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1021\/acs.jmedchem.0c01964","article-title":"Novel sigma 1 receptor antagonists as potential therapeutics for pain management","volume":"64","author":"Peng","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109785_bb0215","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/onc.2011.267","article-title":"Endogenous modulators and pharmacological inhibitors of histone deacetylases in cancer therapy","volume":"31","author":"Spiegel","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2026.109785_bb0220","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1128\/MCB.01154-06","article-title":"Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally","volume":"28","author":"Zhang","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bioorg.2026.109785_bb0225","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.tips.2014.08.001","article-title":"Drugging the HDAC6-HSP90 interplay in malignant cells","volume":"35","author":"Kr\u00e4mer","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2026.109785_bb0230","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.201800599","article-title":"Synthesis and biological evaluation of \u03c31 receptor ligands based on phenyl-1,2,4-oxadiazole derivatives","volume":"16","author":"Cao","year":"2019","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.bioorg.2026.109785_bb0235","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1016\/j.bmc.2015.04.035","article-title":"Fragmentation of GW4064 led to a highly potent partial farnesoid X receptor agonist with improved drug-like properties","volume":"23","author":"Flesch","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109785_bb0240","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.3390\/molecules30081851","article-title":"Synthesis and antifungal activity of 1,2,4-oxadiazole derivatives","volume":"30","author":"Yu","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.109785_bb0245","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1021\/jm4008449","article-title":"Total synthesis and full histone deacetylase inhibitory profiling of azumamides A-E as well as \u03b22-epi-Azumamide E and \u03b23-epi-azumamide E","volume":"56","author":"Villadsen","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109785_bb0250","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/jnc.13907","article-title":"Activation of Nur77 in microglia attenuates proinflammatory mediators\u2019 production and protects dopaminergic neurons from inflammation-induced cell death","volume":"140","author":"Liu","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bioorg.2026.109785_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177919","article-title":"Discovery of two new co-drugs of celecoxib and gabapentinoids for treating chemotherapy-induced peripheral neuropathy","volume":"1003","author":"Yin","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109785_bb0260","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1038\/s41401-025-01570-2","article-title":"Dysfunction of subthalamic dopaminergic circuitry contributes to anxiety- and depression-like behaviors in 6-OHDA lesion-induced hemiparkinsonian mice","volume":"46","author":"Zhang","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bioorg.2026.109785_bb0265","doi-asserted-by":"crossref","first-page":"21223","DOI":"10.1021\/acs.jmedchem.4c02024","article-title":"Deciphering the therapeutic potential of novel pentyloxyamide-based class I, IIb HDAC inhibitors against therapy-resistant leukemia","volume":"67","author":"Fischer","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109785_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113678","article-title":"Discovery of memantyl urea derivatives as potent soluble epoxide hydrolase inhibitors against lipopolysaccharide-induced sepsis","volume":"223","author":"Du","year":"2021","journal-title":"Eur. J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826003214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826003214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T08:21:48Z","timestamp":1776154908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826003214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":54,"alternative-id":["S0045206826003214"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109785","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel HDAC6 inhibitors based on the diphenyl-1,2,4-oxadiazole scaffold with potential efficacy in alleviating inflammation- and chemotherapy- associated mechanical hypersensitivity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109785","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109785"}}